Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Localised oedema
ADR ID BADD_A04765
ADR Hierarchy
02      Cardiac disorders
02.05      Heart failures
02.05.04      Heart failure signs and symptoms
02.05.04.006      Localised oedema
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.07      Oedema NEC
08.01.07.011      Localised oedema
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.06      Total fluid volume increased
14.05.06.009      Localised oedema
Description Not Available
MedDRA Code 10048961
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Labial edema | Lumbar cushion | Neck oedema | Neck oedema of | Oedema auricular | Sacral edema | Sacral oedema | Oedema abdomen | Localised oedema | Neck edema | Edema abdomen | Edema auricular | Localised edema | Neck edema of | Oedema trunk | Edema trunk | Localized edema | Lumbar subcutaneous oedema | Lumbar subcutaneous edema | Chest wall edema | Chest wall oedema
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00858Everolimus0.000413%
BADD_D00979Furosemide0.000014%
BADD_D00981Gabapentin0.000036%
BADD_D00983Gadobenate dimeglumine--
BADD_D00990Gadolinium-dtpa--
BADD_D00991Gadopentetate dimeglumine--
BADD_D01119Ibrutinib0.000246%
BADD_D01120Ibuprofen0.000009%
BADD_D01136Imatinib0.000224%
BADD_D01159Insulin (human)--
BADD_D01180Iohexol0.010670%
BADD_D01182Iopromide0.017783%
BADD_D01186Ioversol0.010670%
BADD_D01194Irbesartan--
BADD_D01242Lamivudine--
BADD_D01243Lamotrigine0.000110%
BADD_D01254Lenvatinib0.000168%
BADD_D01260Leuprolide acetate0.003155%
BADD_D01275Levofloxacin0.000169%
BADD_D01285Levothyroxine0.000022%
BADD_D01295Linezolid0.003293%
BADD_D01334Lymphazurin--
BADD_D01336Macitentan0.000794%
BADD_D01345Magnevist--
BADD_D01433Methylprednisolone0.000070%
BADD_D01449Metronidazole--
BADD_D01470Minocycline0.000260%
BADD_D01476Mirtazapine0.000120%
BADD_D01496Montelukast--
BADD_D01567Nilotinib0.000112%
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages